Table 2.
Evaluation | C | La) | TLa) | LEa) | TLEa) |
---|---|---|---|---|---|
EV1 | −10.76 | −4.07 | −0.91 | −12.29 | −6.14 |
EV2b,c) | 2.85 | −76.43 | −51.5 | −65.56 | −44.44 |
EV3b) | 19.49 | −48.17 | −54.34 | −52.42 | −43.87 |
EV4b) | −0.01 | −56.44 | −48.4 | −48.56 | −59.84 |
EV5b) | 3.25 | −60.9 | −38.12 | −34.00 | −42.23 |
EV6 | −1.61 | −36.68 | −27.46 | −30.19 | −9.71 |
C, control; L, lesion; TL, trained + lesion; LE, lesion + exercise; TLE, trained + lesion + exercise group.
Significant difference compared to C.
Difference compared to EV1.
Difference compared to EV6.